Edition:
United States

Profile: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,546.50GBp
20 Jan 2017
Change (% chg)

-6.50 (-0.42%)
Prev Close
1,553.00
Open
1,550.00
Day's High
1,557.00
Day's Low
1,542.50
Volume
6,319,708
Avg. Vol
9,260,364
52-wk High
1,745.56
52-wk Low
1,314.26

GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company's segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals business develops and makes medicines to treat a range of acute and chronic diseases. The Vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across the world. The Consumer Healthcare business develops and markets products in various categories, such as Wellness, Oral health, Nutrition and Skin health. The Pharmaceuticals Research and Development (R&D) focuses on the discovery and development in various areas of research, which include human immunodeficiency virus (HIV) and infectious diseases, oncology, immuno-inflammation, respiratory and rare diseases.

Company Address

GlaxoSmithKline PLC

980 Great West Road
BRENTFORD     TW8 9GS
P: +4420.80475000
F: +4420.80477807

Company Web Links